Noveris Health Sciences Inc.
OTC: MYCOF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Jason Birmingham
- Employees
- 3
- Headquarters
- Vancouver, Canada
- IPO year
- 2021
- Market cap
- $117.1M
- Website
- https://www.mydecine.com
Loading MYCOF…
Loading profile data…Frequently asked questions about MYCOF
What does Noveris Health Sciences Inc. (MYCOF) do?
Noveris Health Sciences Inc. operates as a biotechnology firm dedicated to the investigation, pharmaceutical development, and clinical evaluation of psilocybin-based products. Co-founded by Parente Carman, Damon Michaels, and Robert Roscow on September 27, 2013, the company maintains its headquarters in Vancouver, Canada.
Where does MYCOF trade?
Noveris Health Sciences Inc. (MYCOF) trades on the Other OTC.
What sector is MYCOF in?
Noveris Health Sciences Inc. (MYCOF) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Noveris Health Sciences Inc.?
Jason Birmingham is the chief executive officer of Noveris Health Sciences Inc. (MYCOF).
Where is Noveris Health Sciences Inc. headquartered?
Noveris Health Sciences Inc. is headquartered in Canada.
Does MYCOF pay a dividend?
Noveris Health Sciences Inc. (MYCOF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MYCOF go public?
Noveris Health Sciences Inc. (MYCOF) completed its initial public offering in 2021.